These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9639551)

  • 21. Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock.
    Yamanaka S; Iwao H; Yukimura T; Kim S; Miura K
    Br J Pharmacol; 1993 Dec; 110(4):1501-7. PubMed ID: 8306093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of platelet-activating factor antagonist on brain injury in rats.
    Tokutomi T; Sigemori M; Kikuchi T; Hirohata M
    Acta Neurochir Suppl (Wien); 1994; 60():508-10. PubMed ID: 7976632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of the platelet-activating factor inhibitor TCV-309 on reperfusion injury in a canine model of ischemic lung.
    Kawahara K; Tagawa T; Takahashi T; Akamine S; Nakamura A; Yamamoto S; Muraoka S; Tomita M
    Transplantation; 1993 Jun; 55(6):1438-9. PubMed ID: 8516834
    [No Abstract]   [Full Text] [Related]  

  • 24. The PAF antagonist TCV-309 reduces graft PMN infiltration and enhances early function of 24-hour-preserved rat kidneys with long warm ischemia.
    Yin M; Buurman WA; Daemen JW; Kootstra G
    Transplantation; 1996 May; 61(10):1443-6. PubMed ID: 8633367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury.
    Stammberger U; Carboni GL; Hillinger S; Schneiter D; Weder W; Schmid RA
    J Heart Lung Transplant; 1999 Sep; 18(9):862-8. PubMed ID: 10528748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-activating factor plays a role in the mechanism of major histocompatibility complex in T lymphocytes.
    Nikbakht-Sangari M; Qayumi AK; Keown P; Duronio V; Horley K
    Immunol Invest; 1999 Jul; 28(4):223-33. PubMed ID: 10454000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with increased extravascular lung water in cardiac tamponade and myocardial ischemia.
    Kitashiro S; Sugiura T; Tamura T; Izuoka T; Miyoshi H; Saito D; Takayama Y; Iwasaka T
    Crit Care Med; 1999 Oct; 27(10):2229-33. PubMed ID: 10548212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of platelet activating factor in development of thrombocytopenia and neutropenia in dogs with endotoxemia.
    Tsuchiya R; Kyotani K; Scott MA; Nishizono K; Ashida Y; Mochizuki T; Kitao S; Yamada T; Kobayashi K
    Am J Vet Res; 1999 Feb; 60(2):216-21. PubMed ID: 10048555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional haemodynamic effects of platelet activating factor in the rat.
    King KA; Lim SL; Pang CC
    Eur J Pharmacol; 1995 Aug; 281(2):187-93. PubMed ID: 7589206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early release of neutrophil chemotactic factor from isolated rat heart subjected to regional ischaemia followed by reperfusion.
    Senoh M; Aosaki N; Ohsuzu F; Nakamura H; Minezaki K; Tuji C; Nakazawa H
    Cardiovasc Res; 1993 Dec; 27(12):2194-9. PubMed ID: 8313428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation.
    Kawamura M; Terashita Z; Imura Y; Shino A; Nishikawa K
    Thromb Res; 1993 May; 70(4):281-93. PubMed ID: 8332959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of platelet activating factor antagonist, TCV309, on the relationship between electrophysiological and mechanical status during myocardial ischemia and reperfusion.
    Tamura K; Kimura Y; Tamura T; Kitashiro S; Izuoka T; Iwasaka T; Inada M
    Ann N Y Acad Sci; 1994 Jun; 723():371-4. PubMed ID: 8030887
    [No Abstract]   [Full Text] [Related]  

  • 34. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
    J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion.
    Ko W; Lang D; Hawes AS; Zelano JA; Isom OW; Krieger KH
    J Surg Res; 1993 Nov; 55(5):504-15. PubMed ID: 8231170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.
    Ogata M; Matsumoto T; Koga K; Takenaka I; Kamochi M; Sata T; Yoshida S; Shigematsu A
    Infect Immun; 1993 Feb; 61(2):699-704. PubMed ID: 8423096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Edema development and recovery in neurogenic pulmonary edema.
    Maron MB; Holcomb PH; Dawson CA; Rickaby DA; Clough AV; Linehan JH
    J Appl Physiol (1985); 1994 Sep; 77(3):1155-63. PubMed ID: 7836117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of inflammatory mediators in the mechanism of the host immune response induced by ischemia-reperfusion injury.
    Nikbakht-Sangari M; Qayumi AK; Keown PA
    Immunol Invest; 2000 Feb; 29(1):13-26. PubMed ID: 10709843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Constriction of canine coronary arteries by platelet activating factor after brief ischemia.
    Kim YD; Danchak RM; Heim KF; Lees DE; Myers AK
    Prostaglandins; 1993 Sep; 46(3):269-76. PubMed ID: 8234834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of TCV-309, a novel platelet activating factor antagonist, on hemodynamics in dogs with endotoxin-induced shock.
    Okano S; Tagawa M; Urakawa N
    J Vet Med Sci; 1995 Apr; 57(2):385-7. PubMed ID: 7492672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.